Agilex Biolabs and Gyros Protein Technologies collaborate to host a webinar on a single analysis bioanalytical area

[ad_1]

Adelaide, Australia, May 31, 2021-(ACN Newswire)-Agilex Biolabs, Australia’s largest and most technologically advanced clinical trial professional bioanalysis laboratory, collaborates with Gyros Protein Technologies and BioAnalysis Zone to share the latest on the Gyrolab platform Single molecule analysis.

Register here https://tinyurl.com/puwwj9zp
Single point analysis on the Gyrolab platform
Wednesday, June 2, 2021
18:00 [EDT] 23:00 [BST] | Thursday, June 3 06:00 [CST] 08:00 [AEST]

Morgan Evans, chief method development scientist at Agilex Biolabs, will participate in a comprehensive webinar titled Singlicate analysis on the Gyrolab platform with John Chappell, Director of Applications and Services for Europe, Middle East and Africa and Asia Pacific of Gyros Protein Technologies.

The theme of the webinar was inspired by the Agilex Biolabs poster presentation “Development and verification of Tocilizumab PK method individually and repetitively on the Gyrolab platform” published at the 13th EBF public seminar.

In the past few years, singlet analysis has become a hot topic in the field of LBA non-regulated and regulated bioanalysis. Many studies have shown that positive results have been achieved in repeat accuracy evaluation and PK/TK parameters.

Due to the high degree of automation and robustness of the instrument, Gyrolab has become the leader in single analysis of LBA technology.

This webinar will focus on the overall prospects of singlet analysis and discuss the use of Gyrolab technology through Agilex Biolabs case studies. It will also look at how lessons learned can inform the prospect of a single analysis on other technology platforms, while keeping in mind “speed to patients” to ensure the efficiency of bioanalytical laboratories.

Agilex Biolabs’ world-class laboratory is equipped with the most advanced equipment, including Gyrolab Xplore, MSD Quickplex 120, Luminex Magpix, BD FACSymphony A3 flow cytometer and the upcoming digital droplet quantitative real-time RT-PCR.

The company uses LC-MS/MS and immunoassay platforms to provide PK, immunogenicity (PD) and biomarker bioanalysis services for small molecules and biological agents.

Australian clinical trials are still open, and Agilex Biolabs is the designated basic service, so customers can ensure the continuity of research.

Agilex Biolabs has more than 120 employees, including 85 dedicated laboratory employees, and supports client pharmaceutical and biotech companies from the United States, Europe and the Asia-Pacific region.

Before you start your next clinical trial, schedule a confidential briefing with our scientists. https://calendly.com/agilexbiolabs/15min

About Agilex Biolabs – https://www.agilexbiolabs.com/

Agilex Biolabs is Australia’s leading bioanalysis laboratory with more than 24 years of experience in performing regulatory bioanalysis, including quality method development, method validation and sample analysis services. It has successfully supported hundreds of pre-clinical and clinical trials from all over the world. Customers choose Australia to simplify the regulatory process and obtain the most attractive R&D rebate in the world. More than 40% of the clinical trial work conducted in Australia. Agilex Biolabs also provides toxicology services through its TetraQ company, which is a mature GLP rodent toxicology facility in Australia.

Agilex Biolabs has leading certifications, including OECD GLP accreditation and NATA (the Australian Government OECD GLP compliance monitoring agency) and ISO 17025 global accreditation certification. The company recently expanded its main laboratory by more than 30% to meet biotechnology needs in the Asia-Pacific region and the United States.To watch the new lab video walkthrough, please visit https://www.agilexbiolabs.com/new-labs-video

Agilex Biolabs specializes in the use of LC-MS/MS, immunoassays (Mesoscale, Gyrolab, Luminex) and flow cytometry (BD FACSymphony A3, 20-color cytometer) for biological analysis of small molecules and biological agents for PK and immunity Evaluation of originality, biomarkers and immunopharmacodynamics.

Agilex provides pharmacodynamic services, including immunobiology services that use the latest and most advanced technologies to support immunology, cell biology and mode of action analysis, including:
-Immunophenotype
-Receptor occupancy
-Cytokine release analysis (whole blood or PBMC stimulation analysis) and cytokine/biomarker analysis
-PBMC detection and cell mechanism detection

Agilex Biolabs Media Contact:
Kate Newton
Media@AgilexBiolabs.com

Source: Agilex Biolabs

Copyright 2021 ACN News Line. all rights reserved.

[ad_2]

Source link

Recommended For You

About the Author: News Center